...
首页> 外文期刊>Hormone and Metabolic Research >The expression and regulation of bone-acting cytokines in human peripheral adipose tissue in organ culture.
【24h】

The expression and regulation of bone-acting cytokines in human peripheral adipose tissue in organ culture.

机译:器官培养中人外周脂肪组织中骨作用细胞因子的表达和调控。

获取原文
获取原文并翻译 | 示例

摘要

The humoral cross-talk between bone and fat is an area of increasing interest. We investigated the expression and regulation of the bone-acting cytokines; bone morphogenetic protein 2 (BMP2), connective tissue growth factor (CTGF), osteoprotegerin (OPG), and transforming growth factor beta (TGFB1). Subcutaneous adipose tissue was aspirated from lean, healthy women. Tissue samples were incubated with interleukin 1-beta (IL1-beta), tumor necrosis factor-alpha (TNF-alpha), cortisol, troglitazone, IL1-beta + troglitazone, or vehicle. Gene expression in the adipose tissue was analyzed using qPCR and protein levels in the incubation media were analyzed using ELISA. OPG expression and secretion was diminished by 40.8% and 43.1% respectively, by cortisol, and OPG expression was diminished by 67.5% by troglitazone (p<0.05). The proinflammatory cytokines IL1-beta and TNF-alpha significantly increased the expression of CTGF (p<0.05) by 65.1% and 101.3%, respectively, and the expression and secretion of OGP by 62.3-165.8% (p<0.05). This interleukin 1-beta mediated increase in CTGF- and OPG expression and secretion was ameliorated by troglitazone. Troglitazone and related drugs are known to have adverse effects on bone. We suggest that this could be mediated via altered cytokine production in adipose tissue. Moreover, obese individuals have a low-grade inflammation in their adipose tissue and have higher bone mineral density than lean individuals. We suggest that this inflammation may increase the expression and secretion of OPG and CTGF and thereby increase BMD. In conclusion, bone acting cytokines are produced in the adipose tissue and may affect bone through endocrine mechanisms.
机译:骨骼和脂肪之间的体液互动是人们越来越感兴趣的领域。我们研究了骨作用细胞因子的表达和调控。骨形态发生蛋白2(BMP2),结缔组织生长因子(CTGF),骨保护素(OPG)和转化生长因子β(TGFB1)。从瘦的健康妇女中抽吸皮下脂肪组织。将组织样品与白介素1-beta(IL1-beta),肿瘤坏死因子-α(TNF-alpha),皮质醇,曲格列酮,IL1-beta +曲格列酮或媒介一起孵育。使用qPCR分析脂肪组织中的基因表达,并使用ELISA分析孵育培养基中的蛋白质水平。皮质醇使OPG表达和分泌分别减少40.8%和43.1%,曲格列酮使OPG表达减少67.5%(p <0.05)。促炎细胞因子IL1-β和TNF-α分别显着增加CTGF的表达(p <0.05)65.1%和101.3%,OGP的表达和分泌66.2-165.8%(p <0.05)。曲格列酮改善了白介素1-β介导的CTGF-和OPG表达和分泌的增加。曲格列酮和相关药物已知对骨骼有不良影响。我们建议这可以通过改变脂肪组织中细胞因子的产生来介导。此外,肥胖的人的脂肪组织炎症较轻,而肥胖的人的骨矿物质密度更高。我们建议这种炎症可能会增加OPG和CTGF的表达和分泌,从而增加BMD。总之,在脂肪组织中会产生具有骨骼作用的细胞因子,并可能通过内分泌机制影响骨骼。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号